newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra
Corporate Press Release

Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited’ Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav.

USFDA inspection at Alembic Pharmaceuticals Limited’ Oncology

9th October, 2024, Bengaluru: Alembic Pharmaceuticals today announced that it has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Oncology (Injectable and Oral Solid) Formulation Facility (F-2) located at Panelav.

The inspection was successfully completed without any Form 483 observation. The inspection was conducted from 7th October, 2024 to 8th October, 2024.

Related posts

Wadhwani AI Signs MoU with NSDC to Deploy AI-based Skilling Solution

VyapaarJagat Growth Show Announced to Celebrate National Startup Day and to Nurture and Encourage Entrepreneurship at World Trade Center

UST Secures First Three Places at the Capture the Flag (CTF) Competition at India’s Prestigious Cybersecurity Event – c0c0n 2024 

Newsmantra

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More